$10.8

Merck & Co. will buy Prometheus Biosciences Inc. for about $10.8 billion, a 75% premium to Friday's close, in a bid to bolster its research … from Google Alert – international law https://ift.tt/gH7TrA8 April 16, 2023 at 11:21PM

The agreement to buy the biotech company, one of the largest pharma deals in recent history, comes as Merck's blockbuster cancer drug, Keytruda, faces … from Google Alert – international law https://ift.tt/xrLOT79 April 16, 2023 at 11:15PM